Skip to main content
logo
Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.210
+0.075 (6.61%)
Sep 18, 2026, 3:57 PM HKT

HKG:0950 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
119.7791.9493.116.751.281,987
Depreciation & Amortization
122.0897.5999.3107.95125.52126.97
Other Amortization
58.0658.0648.4341.5526.9819.9
Loss (Gain) From Sale of Assets
0.20.2-0.14-41.63-0.24-0.04
Asset Writedown & Restructuring Costs
16.5216.5225.9133.312.68235.09
Loss (Gain) From Sale of Investments
-0.35-0.350.381.4346.36-2,300
Loss (Gain) on Equity Investments
1.851.850.840.871.13.5
Stock-Based Compensation
0.520.520.410.7912.1116.89
Provision & Write-off of Bad Debts
0.160.1613.71.28-0.2690.28
Other Operating Activities
7.9910.0611.0726.1633.1-33.8
Change in Accounts Receivable
-19.22-19.22-82.4621.0939.9-1.95
Change in Inventory
-83.39-83.39-7.22-61.9643.2843.34
Change in Accounts Payable
28.1328.1369.98-26.8239.48-11.35
Change in Other Net Operating Assets
130.85130.85-31.28-10.63-137.6734.47
Operating Cash Flow
383.15332.9242.01110.08283.63210.68
Operating Cash Flow Growth
4.30%37.56%119.85%-61.19%34.63%-3.76%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-109.44-66.63-43.96-29.43-17.46-50.7
Sale of Property, Plant & Equipment
0.090.090.240.110.880.04
Cash Acquisitions
----0.02--
Sale (Purchase) of Intangibles
-179.59-164.93-141.54-110.72-196.37-320.03
Investment in Securities
-7-7-8.64-6.7-45.5-2.17
Other Investing Activities
-0.212.73.661.532.392.58
Investing Cash Flow
-296.15-235.77-190.23-145.22-256.05-370.28

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-271.73183.92104.4560227.37
Total Debt Issued
271.73271.73183.92104.4560227.37
Long-Term Debt Repaid
--208.47-168.21-80.41-164.45-134.02
Lease Payments
-11.09-11.09-10.12-11.48-12.57-11.41
Total Debt Repaid
-208.47-208.47-168.21-80.41-164.45-134.02
Net Debt Issued (Repaid)
63.2663.2615.7124.04-104.4593.35
Issuance of Common Stock
-----3.54
Common Dividends Paid
-26.5-27.68-17.67-10.6-24.14-35.92
Other Financing Activities
-71.6-----
Financing Cash Flow
-34.8435.58-1.9613.44-128.660.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
8.65-4.12-0.51-0.0812.790.96
Net Cash Flow
60.81128.649.32-21.77-88.23-97.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
273.71266.27198.0680.65266.18159.99
Free Cash Flow Growth
-15.78%34.44%145.58%-69.70%66.37%98.70%
Free Cash Flow Margin
17.80%18.54%14.15%7.66%21.58%12.64%
Free Cash Flow Per Share
0.470.450.340.140.450.27
Levered Free Cash Flow
-11.0828.6449.6-44.9768.9-177.85
Unlevered Free Cash Flow
-4.835.4258.24-37.9273.04-175.1
Free Cash Flow After Leases
262.63255.19187.9469.17253.6148.58

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.2710.0212.7710.46.243.79
Cash Income Tax Paid
18.7615.7710.619.54-12.8864.18
Change in Working Capital
56.3756.37-50.99-78.33-15.0164.52